Company: OTSA
Filing Date: 2025-06-09
Form Type: F-1
Source: 0001213900-25-052720
Chunk: 30

Company: OTSAW Ltd
Filing Date: 2025-06-09
Form: F-1
Chunk 30
---
 effects on our business, prospects, financial condition and operating results which could cause actual results to differ materially from any forward-looking statements expressed by us and a significant decrease in the value of our Class A Ordinary Shares. Refer to “Special Note Regarding Forward-Looking Statements”. We may not be successful in preventing the material adverse effects that any of the following risks and uncertainties may cause. These potential risks and uncertainties may not be a complete list of the risks and uncertainties facing us. There may be additional risks and uncertainties that we are presently unaware of, or presently consider immaterial, that may become material in the future and have a material adverse effect on us. You could lose all or a significant portion of your investment due to any of these risks and uncertainties. Risks Related to our Business and Industry We are an early-stage company with a history of losses and expect to incur significant expenses for the foreseeable future. We have incurred net losses of US$6.5 million and US$6.7 million for the fiscal years ended April 30, 2024 and 2023, respectively. We have incurred net losses of US$3.3million and US$2.9million for the six months ended October31, 2024 and 2023, respectively. We believe that we will continue to incur operating and net losses for the foreseeable future. We might not ever become profitable or achieve net income. We expect that our operating expenses will increase as we grow our business, including expending substantial resources for research and development, sales and marketing, implementing our growth strategies, and expansion of our production capacity. As a result, any decrease in revenues or delay in generating new revenues could result in material operating losses. We expect to continue to incur losses and increasing expenses in the foreseeable future as we: •continue to design and develop our products, including the next -generationTransCar and Odyssey ANS; •build up inventories of parts and components for our products; •manufacture an available inventory of our products; •fulfil the call/put arrangement of the Otsaw -SwisslogHealthcare Joint Venture; •expand our design, research, development, maintenance and repair capabilities; •increase our sales and marketing activities and develop our regional centers in Europe and the United States; and •expand our general and administrative functions to support our growth and operations and the status as a public company. As described in the report of our auditors for the years ended April 30, 2024, and 2023 and the notes to